SWK Holdings Corporation SWKH
At closeApr 6, 2026, 4:00 PM EDT
After hours · Apr 6, 4:00 PM ET
52-week range unavailable
- YTD
- -7.56%
- 1 year
- -12.15%
- Market cap
- 196.10M
- Revenue (ttm)
- 25.77M
- Profit margin
- 45.95%
- Shares out
- 12.23M
- Forward P/E
- 8.10
- YTD return
- -7.56%
- 1-year return
- -12.15%
- Volume
- 105.55K
- Open
- 15.90
- Previous close
- 15.90
- Day's range
- 15.90 – 15.90
- Beta
- 0.36
- Price target
- 22.00 (+38.4%)
Key statistics
- Enterprise value
- 223.07M
- PEG ratio
- 0.00
- Price / sales
- 7.61
- Price / book
- 0.71
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -35.30%
- Free cash flow
- 0
- Total cash
- 9.01M
- Total debt
- 31.08M
- Return on equity
- 4.25%
- Short % of float
- 1.48%
- 50-day average
- 16.38
- 200-day average
- 16.94
Analyst view
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.94.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | 0.33 | — | — |
| Aug 15, 2024 | Jun 1, 2024 | 0.00 | 0.46 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | 0.12 | — | — |
| Mar 21, 2024 | Dec 1, 2023 | 0.00 | 0.23 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.38 | — | — |
| Aug 9, 2023 | Jun 1, 2023 | 0.00 | 0.40 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 4, 2023 | Maxim Group | main | — | Buy |
About SWK Holdings Corporation
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
- Website
- swkhold.com
News
Stanley Black & Decker, Inc. (SWK) Hit a 52 Week High, Can the Run Continue? 
Why Stanley Black & Decker (SWK) is a Top Value Stock for the Long-Term 
Stanley Black & Decker (SWK) Reports Next Week: Wall Street Expects Earnings Growth 
SWK or LECO: Which Is the Better Value Stock Right Now? 
What Makes Stanley Black & Decker (SWK) a New Buy Stock 
Stanley Black & Decker (SWK) is a Top-Ranked Value Stock: Should You Buy? 
Has Stanley Black & Decker (SWK) Outpaced Other Industrial Products Stocks This Year? 
SWK vs. LECO: Which Stock Is the Better Value Option? 
Is Stanley Black & Decker (SWK) Stock Undervalued Right Now? 
Will Stanley Black & Decker (SWK) Beat Estimates Again in Its Next Earnings Report?
Your note
Sign in to keep a note on SWKH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALBRIGHT JERRY G | Director | Stock Award(Grant) | Jun 26, 2024 | 6,974 |
| DICICCO WENDY FRANCES | Director | Stock Award(Grant) | Dec 29, 2022 | 6,182 |
| DOTTER LAURIE L | Director | Stock Award(Grant) | Jun 26, 2024 | 12,933 |
| HATCHER ROBERT K. | Director | Stock Award(Grant) | Jun 26, 2024 | 12,804 |
| PENNINGTON MARCUS EDWARD | Director | Stock Award(Grant) | Jun 30, 2024 | 22,227 |
| RICE ADAM | Chief Financial Officer | Stock Award(Grant) | Jul 2, 2024 | 6,072 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Carlson Capital. L.P. | 70.43% | 9,093,766 | 145.77M | Sep 29, 2024 |
| M3F, Inc. | 6.05% | 780,872 | 12.52M | Sep 29, 2024 |
| Cannell Capital LLC | 2.96% | 381,838 | 6.12M | Sep 29, 2024 |
| Vanguard Group Inc | 2.08% | 267,961 | 4.30M | Sep 29, 2024 |
| Blackrock Inc. | 1.11% | 143,916 | 2.31M | Sep 29, 2024 |
| Bridgeway Capital Management, Inc. | 0.84% | 108,985 | 1.75M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.07% | 138,755 | 2.22M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.81% | 104,834 | 1.68M | Sep 29, 2024 |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | 0.40% | 51,880 | 831.64K | Sep 29, 2024 |
| iShares Russell 2000 ETF | 0.32% | 40,887 | 655.42K | Oct 30, 2024 |
| iShares Russell 2000 Value ETF | 0.29% | 36,960 | 592.47K | Oct 30, 2024 |
| Fidelity Small Cap Index Fund | 0.24% | 31,269 | 501.24K | Aug 30, 2024 |